The National Health and Nutrition Survey conducted by the Ministry of Health, Labour and Welfare of Japan in 2016 revealed that 21.1% of men and 24.8% of women showed high low-density lipoprotein cholesterol (LDL-C) levels (≥ 140 mg/dL), which indicated a higher mean cholesterol level in women than in men. Higher LDL-C values in women than in men have been noted for a long time, and it is speculated that menopause is one of the factors that affect elevated LDL-C levels in women. Despite elevated LDL-C in women, it is well recognized that women are not prone to developing arteriosclerotic lesions. The Japan Atherosclerosis Society has published "Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017" and provided risk stratification charts according to the Suita score system, which was developed in the Suita study. These risk charts were provided based on the lipid level and classical cardiovascular risk factors, and cardiovascular events have been set as end points with detailed treatment goals in the guidelines. Unfortunately, gender differences have not been considered in treatment goals in the guidelines, even though women carry a lower risk of cardiovascular events than men. In this sense, it might be a better idea to determine the adaptation of high LDL-C treatment by statins after using carotid artery ultrasound to check for the presence of atherosclerotic lesions, carotid intima-media thickness (IMT), or plaques. It has been reported that efficient high LDL-C therapy with statins reduces plaque development more effectively in women than in men. In addition, it is important for health care professionals who provide instructions regarding diet and nutrition to understand that dietary nutrients that affect LDL-C level are not cholesterol derived from food, but mainly the intake of saturated fatty acids and trans-unsaturated fatty acids.
Introduction
In Europe and the United States, several large-scale clinical studies have been conducted regarding the development of atherosclerotic cardiovascular diseases, including how dyslipidemia is involved in atherosclerosis and how treatment approaches affect these disease. These results suggest that gender differences might exist in the development of dyslipidemia and atherosclerotic cardiovascular diseases. Considering these facts, men and women should have separate therapeutic procedures for dyslipidemia, which has led to the creation of separate treatment guidelines since the 1990s. In the cohort study in Japan, there are few studies that indicated dyslipidemia as a risk factor for cerebrovascular disease 1) , and such Japanese outcome studies that evaluated stroke and/or cerebral infarction did not include hypercholesterolemia as one of risk factors. Japanese cohort studies that incorporated both LDL-C and high density lipoprotein cholesterol (HDL-C) which are important for settling the management target values of dyslipidemia as predictive indices, and that included both myocardial infarction and onset of coronary artery disease widely as outcome were only Suita study 2) and Hisayama study 3) . In Japan the proportion of stroke in cerebrovascular disease is high, and in fact, the ratio of stroke and coronary artery disease in Hisayama study was 2:1; however, the proportion of atherothrombotic cerebral infarction which results from high LDL-C as the main risk factor is less than 20%. From the viewpoint that the risk assessment of dyslipidemia can be evaluated finely from five ranks of LDL-C, Japan Atherosclerosis Society (JAS) selected results of Suita study to assess the absolute risk for the primary prevention of Japanese general adult population. By using Suita score to stratify the risk for developing coronary artery disease in 10 years, JAS published "JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 4) ".
Changes in serum lipid levels and development of coronary artery disease by age in Japanese men and women men; however, the levels tended to elevate after menopause, and to reach the mean LDL-C levels stratified by age close to those of men (Fig. 1) . Regarding triglyceride levels, a sharp increase after menopause is observed in women while they remain high in men at the same age, which resulted in men showing higher triglyceride levels than women at older ages. Although LDL-C levels are higher in women than in men, those for women will slightly decrease after menopause. The vital statistics published by the Ministry of Health, Labour and Welfare in 2016 6) showed that the death rates from acute myocardial infarction in women in their fifties, sixties, and seventies were 15.1%, 23.3%, and 41.1%, respectively, of those of men. The incidence of or mortality from coronary heart disease in women are later than those for men by ten years, which is related to estrogenic concentrations and the lifestyles of women. Since the life expectancy of women has become longer in recent years, leading to an increase in the total number of deaths from coronary artery disease, application of therapeutic interventions must be considered accordingly. The results of a cohort study conducted in Japan revealed that both total cholesterol and LDL-C levels were positively correlated with the mortality rate from coronary artery disease in men, whereas in women, it did not increase despite total cholesterol and LDL-C levels being considerably higher than those of men.
In addition, a unique large-scale clinical intervention study in Japan (the MEGA Study) showed that the administration of pravastatin to patients with hypercholesterolemia reduced the incidence of coronary artery disease in all subjects as well as women older than 55 7, 8) . In many cases, clinical studies on coronary artery disease in Japan did not reach a sufficient number of coronary events from the statistical point of view when MACE (sudden cardiac death, non-fatal myocardial infarction, cerebral infarction) was set as the end point of the study; thus, other variables such as hospitalization due to unstable angina are also set as end points of the studies 9) . It appeared that MACE events do not increase dramatically, probably due to diagnosis and treatment in the initial stages of coronary artery disease in Japan.
Gender difference should be considered in practical dyslipidemia treatments
So far it has been reported that although IMT has a significant relationship with cerebrovascular disease, but not with coronary artery disease. However, concerning the development of coronary artery disease, according to the Multi-Ethnic Study of Atherosclerosis 10) in which IMT was measured in 6,606 subjects (mean age, 62.1years; 52.7% women), the prediction of coronary artery disease onset using IMT of the far side wall of common carotid artery was reported to exceed that using Framingham risk factor (change in C statistic, 0.012; 95% CI, 0.006 -0.017; p < 0.001).
In the JART study 11) , measurements of IMT have been standardized using less than 400 patients who had carotid artery wall thickness or atherosclerotic lesions (plaques) (IMT ≥ 1.1 mm) and high LDL-C. The patients were divided into a normal treatment group using a mild statin and a potent (aggressive) treatment group where LDL-C levels were expected to decrease considerably (primary prevention: LDL-C levels were set less than 80 mg/dL) with a strong statin based on the treatment guidelines established by the Japan Atherosclerosis Society. IMT was measured at the beginning of the study, and one year and two years from the beginning, and mean IMT changes were analyzed. At one-year follow-up, mean IMT increased in subjects in the mild statin group, whose mean LDL-C was 118 mg/dL, whereas IMT increments were not apparent in the subjects in the strong statin group, whose mean LDL-C was 85 mg/dL. The difference in mean IMT changes in both groups was statistically significant. Due to IMT increments in the subjects with mild statin treatment, the JART study was discontinued after one-year follow-up, but the discontinued patients and the potent treatment group were further followed up for one more year. The results from further follow-up indicated that the mean IMT further increased in the subjects in the normal treatment group, while mean IMT decreased in the subjects in the potent treatment group 12) . Moreover, gender differences were noted in this study: no significant differences in the change in mean IMT were observed in men between the two groups, while significant differences were observed in women, in that lowering LDL-C effectively reduced atherosclerosis. Therefore, it is suggested that potent statin therapy is more effective for female patients with thickened IMT diagnosed by carotid artery echography. On the other hand, IMT is not apparent in considerable numbers of women despite high LDL-C. Even when carotid artery echography is not performed, it can be assumed that IMT thickening is often absent if women with high LDL-C have no other risk factors for cardiovascular diseases, as indicated by comprehensive physical examinations or regular health check-ups, and the ratio of LDL-C to high-density lipoprotein cholesterol (HDL-C) is not more than 2.5 to 3.0. In these cases, lifestyle improvement including diet therapy should be considered as the first choice. It is desirable to carry out follow-up changes in IMT over time if carotid artery echography can be performed in optional comprehensive physical examinations or routine check-ups.
Assessment of eating habits recommended by the Ministry of Health, Labour and Welfare
Key nutritional factors that increase LDL-C are excessive intake of saturated fatty acids and limited intake of polyunsaturated fatty acids; thus, it has been suggested that the amount of cholesterol intake from food is not always related to serum LDL-C in Japan 13) . Trans-unsaturated fatty acids are reported to contribute to LDL-C elevation. In the "Dietary Reference Intakes for Japanese (2015)" by the Ministry of Health, Labour and Welfare, it is recommended that saturated fatty acid intake should be less than 7.0% of total energy intake 14) . On the other hand, no reference value for the consumption of cholesterol was set, for the reason that there was no evidence to support the association of cholesterol intake with serum LDL-C. In addition, the Dietary Reference Intakes also explained for the first time that limiting egg consumption was not desirable nutritionally. It is necessary for health care professionals to provide patients with instructions for nutrition and diet therapy based on accurate findings and knowledge of nutritional science. Because the LDL-C is affected by diet therapy continuing for at least two weeks, it is advisable to keep track of the intake of total energy, saturated fatty acids, total fats, dietary fibers, and so on by an assessment of eating habits for one month. The Ministry of Health, Labour and Welfare recommends a brief-type self-administered diet history questionnaire as a tool for the assessment 15, 16) .
Management of dyslipidemia in women based on the "JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Disease 2017"
Currently the incidence rate of coronary artery disease among women in Japan is considerably lower than those in Europe and the United States . Appropriate treatments for hypertension have also been found to decrease the incidence of cerebrovascular diseases. On the other hand, new concerns have arisen as to factors increasing incidence of atherosclerotic cardiovascular events, including Westernization of dietary habits, lack of physical activities, and smoking habits among 10 to 15% of women in their twenties and thirties in a 2016 study 18) . It is emphasized that women should manage other cardiovascular risk factors (i.e., obesity, hypertension, diabetes, and lifestyle-related factors including smoking) despite menopause status in a guideline statement (evidence level E-1a, which is based on a meta-analysis of cohort studies). It is suggested that diabetes and smoking in women are stronger risks for coronary artery disease than in men. In the "JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Disease 2017," the treatment goals ( Table 1 , 2) are divided into two categories: primary prevention and secondary prevention. Primary prevention is further divided into three groups stratified by risk categories. The targets for primary prevention are determined by the probability of coronary artery disease development in the next ten years based on the Suita (Table 2) (<70)* (<100)* <150 ≥ − 40
1. For primary prevention, in principle, life-style factors should be modified, then the administration of medications should be considered 2. The administration of drug therapy together with lifestyle modification is desirable in secondary prevention patients LDL-C: low-density lipoprotein cholesterol Non HDL-C: non-high-density lipoprotein cholesterol TG: Triglyceride HDL-C: high-density lipoprotein cholesterol CHD: coronary heart disease score. Since it is well recognized that women in Japan show less probability than men for the development of coronary artery disease, with the Suita score system, seven points are deducted for being a female, and both men and women with diabetes, chronic kidney disease (CKD), non-cardiogenic cerebral infarction, or peripheral arterial disease are categorized into the highrisk group in the Guidelines (Fig. 2) .
The Suita Score system is proposed to estimate probabilities for development of coronary artery disease in the next ten years. Scores are calculated based on age, gender, current smoking status, blood pressure, HDL-C and LDL-C, impaired glucose tolerance, and family history of cardiovascular disease, and risk categories (low, moderate, and high) are estimated by the resulting scores (Fig. 2-2, Table 3 ). Subjects with a total score of less than 40 are estimated to have less than a 2% probability of cardiovascular disease and categorized as low risk. Subjects with a total score of 41 to 55 are estimated to have a 2% to 5% probability of cardiovascular disease and categorized as moderate risk. Subjects with a total score of more than 57 are estimated to have more than a 9% probability of cardiovascular disease and categorized as high risk. The other chart of stratification based on the number of risk factors where gender and age was taking into consideration was also created; and it has been confirmed that this chart was almost in agreement with the stratification category which was categorized and simulated by Suita score. Regarding the flow chart using the number of risk factors, its consistency was pursued with the "Comprehensive risk management chart for the prevention of cerebro-and cardiovascular diseases 2015" 19) developed jointly by 13 academic societies including the Japan Medical Society. The JPHC Study 20) and the Suita Study 21) reported that the incidence rate of myocardial infarction in women who smoked cigarettes was three to eight times higher than in non-smokers. Therefore, for premenopausal women, improving their lifestyle should be the first choice for the treatment of dyslipidemia. For postmenopausal women, although improving their lifestyle will also be the first choice for dyslipidemia treatment, medication should be also considered for patients with high risk. The results from the Japan Collaborative Cohort Study (JACCS) indicated that cigarette smoking seemed to present a much higher risk for women than for men, since the odds ratio for cardiovascular events in men was 4.0, while it was 8.2 in women 22) . The results from another study indicated that cigarette smoking in women showed a greater risk of coronary artery disease than in men 23) . Cardiovascular risk due to smoking could be reduced by its cessation 21) . Since cardiovascular risk can be reduced by smoking cessation regardless of age, emphasis might be placed on the importance of quitting smoking. Awareness regarding never trying smoking should be considered for adolescents.
Points to keep in mind regarding the JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Disease 2017
The scores of the guideline are basically prepared on the premise that they are counted when treatment has not been started including that for dyslipidemia. Currently, concerning the presence and absence of treatment only two scores from JPHC study 20, 24) take into consideration the medication only for hypertension; however, there are no risk scores in which status with or without treatment for dyslipidemia or diabetes is taken into consideration. Presently, risk scores are counted for convenience whether medication is given to the subjects or not. But, for example, the risk of cerebral cardiovascular disease is different in patients with hypertension between those who with and without antihypertensive treatment. On the other hand even if blood pressure of hypertensive patients is lowered with an antihypertensive drug to the same level to the subjects without hypertension and no medication, the risk is higher in the former compared with the latter 25) . Therefore, it should be noted that the actual onset risk of those with medication may be higher than the risk calculated from the score. It is pointed out that the incidence of coronary artery disease in Japan revealed regional difference and difference between groups; such that it is higher in urban areas and lower in rural areas 26) . Thus, it is necessary to recognize that there may be doubt as to whether the absolute risk evaluated by the Suita score can be representative for national population. In the Suita study, the incidence of coronary artery disease is thought to be higher than that from another cohort studies. The Suita study includes coronary artery intervention is as one of outcomes. Therefore, it should also be noted that the absolute risk of coronary artery disease is calculated even higher than that of another cohort studies.
Although Suita score contains overlaps in the score of each group in each category group compared with that of "Comprehensive risk management chart for the prevention of cerebro-and cardiovascular diseases 2015", they are considered to render within a tolerable range. Thus, both are thought to be useful as simple methods based on the number of risk factors.
Conclusions
Women live longer than men, leading to greater opportunities to develop atherosclerosis in their later life, women should be evaluated regarding cardiovascular risk even in younger ages and for the lifetime risk of developing atherosclerotic cardiovascular diseases. Although the recent risk stratification based on the Suita score system in the "JAS Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017" is important, it is also helpful to examine the existence of IMT or plaques using carotid artery echography. Furthermore, improvement of eating habits after detailed assessment by professionals might be also required. 
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